Organ-on-a-Chip: Global Markets

Report Highlights

The global organ-on-a-chip market should reach $183.4 million by 2026 from $32.0 million in 2021 at a compound annual growth rate (CAGR) of 41.8% for the forecast period of 2021 to 2026.

Report Includes

• 55 data tables and 29 additional tables
• An up-to-date review and analysis of the global markets for organ-on-a-chip within the biotech industry
• Analyses of the global market trends, with data from 2019 to 2021, and projections of compound annual growth rates (CAGRs) through 2026
• Information on multi-channel 3-D microfluidic cell culture chip, and discussion of their ability to imitate human microenvironment in vitro
• Evaluation and forecast the global organ-on-a-chip market size, and corresponding market share analysis by technology offering, organ type, application, end-user vertical and region
• Discussion on how organ-on-a-chip is emerging as a priority testing alternative which is replacing animals in life science research, toxicology testing and drug development studies
• Review of potential applications in pharmaceutical and life science research sectors, including preclinical drugs testing, drug screening, personalized medicine, phenotypic screening, lead optimization and disease modelling
• Insights into the recent industry structure including the government programs and policies in support of organ-on-a-chip and coverage of revised laws involving animal testing
• Review of patent grants for innovations in organ-on-a-chip technology across each major category
• Descriptive company profiles of the leading global players, including 4Dcell, BiomimX, Emulate Inc., Kirkstall Ltd., Nortis and TissUse GmbH

Report Scope

The scope of this report covers various types of products available in the organ-on-a-chip market and potential application sectors in various industries. The organ-on-a-chip market is broken down into various segments. Revenue forecasts from 2019 to 2026 are given for each type, application, offering and end user. Revenue generated from the installation and maintenance of instruments has been excluded from the report. The application segment is characterized by various types, including drug discovery and development, toxicological research, and physiological model development, and by end-use industry, including academic and research institutes, pharmaceutical and biotechnology companies, cosmetics industry and other end users. By type market is segmented to liver, lung, kidney, heart and others. The report also focuses on regional segmentation of the market.

Further, it explains the major drivers and regional dynamics of the global market and current trends within the industry. It also includes information about the industry structure and competitive landscape as well as the impact of COVID-19 on the market. The report includes detailed profiles of the major players in the global organ-on-a-chip market.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

• Cell and Gene Therapy Tools, and Reagents: Global Markets (BIO208C)
• Single-use Technologies for Biopharmaceuticals: Global Markets (BIO099F)
• Induced Pluripotent Stem Cells: Global Markets (BIO135F)
• Commercial Amino Acids (BIO007N)
• Technical Textiles: Global Markets (CHM136C)